Stock data
Arcutis Biotherapeutics, Inc. (ARQT)
Arcutis Biotherapeutics, Inc. (ARQT) reported revenue of US$376.07M and net income of -US$16.14M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$376.07M | — | -US$12.23M | -US$16.14M | — |
| 2024 | US$196.54M | — | -US$128.40M | -US$140.04M | — |
| 2023 | US$59.61M | — | -US$241.10M | -US$262.14M | — |
| 2022 | US$3.69M | — | -US$301.63M | -US$311.46M | — |
| 2021 | — | — | -US$206.53M | -US$206.36M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$129.86M | US$15.01M | — |
| 2026-03-31 | US$105.40M | -US$11.29M | — |
| 2025-12-31 | US$129.50M | US$17.39M | — |
| 2025-09-30 | US$99.22M | US$7.41M | — |
| 2025-06-30 | US$81.50M | -US$15.89M | — |
| 2025-03-31 | US$65.85M | -US$25.06M | — |
| 2024-12-31 | US$71.36M | -US$10.79M | — |
| 2024-09-30 | US$44.76M | -US$41.54M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.